Skip to main content
Mahvish Muzaffar, MD, Oncology, Greenville, NC, ECU Health Medical Center

MahvishMuzaffarMD

Oncology Greenville, NC

Hematologic Oncology

Associate Professor Program Director Hematology Oncology Fellowship Brody School of Medicine/East Carolina University

Dr. Muzaffar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Muzaffar's full profile

Already have an account?

  • Office

    524 Moye Blvd, Greenville, NC 27834
    Vidant Cancer Care at the Eddie and Jo Allison Smith Tower in Greenville
    Greenville, NC 27834
    Phone+1 252-816-2273
  • Is this information wrong?

Education & Training

  • University of Toledo
    University of ToledoFellowship, Hematology and Medical Oncology, 2011 - 2013
  • University of Toledo
    University of ToledoResidency, Internal Medicine, 2008 - 2011
  • Alma Atinskij Med Inst
    Alma Atinskij Med InstClass of 1998

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2013 - 2024
  • OH State Medical License
    OH State Medical License 2008 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Metastatic pattern and tumor sidedness in colorectal cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • How Coronavirus Changed Our Health Behaviors
    How Coronavirus Changed Our Health BehaviorsNovember 2nd, 2020
  • Greenville Doctors Give Breast Cancer Screening Advice
    Greenville Doctors Give Breast Cancer Screening AdviceOctober 28th, 2016
  • Outcomes Poorer for Black Patients with Early Breast Ca -Five-year disease-specific survival 94% vs 99% for whites
    Outcomes Poorer for Black Patients with Early Breast Ca -Five-year disease-specific survival 94% vs 99% for whitesAugust 9th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations